Plamumab 40mg Injection (0.8ml Each)

Navigating your medication can sometimes be challenging. This page addresses common questions and provides detailed information about Plamumab 40mg Injection (0.8ml Each), including its uses, how to take it correctly, what side effects might occur, and important advice on managing your treatment effectively. We aim to make understanding Plamumab 40mg Injection (0.8ml Each) as clear and straightforward as possible for you.

MRP: ₹
Packing: 1.0 Injection in 1 prefilled syringe
Salt Combination: Adalimumab (40mg)
Brand: Cipla Ltd
Uses: Ulcerative colitis,Crohn’s disease,Psoriasis,Ankylosing spondylitis,Rheumatoid arthritis

Description

Plamumab 40mg Injection (0.8ml Each) is a medicine used to treat a variety of conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease
It provides relief from swelling, pain, and redness associated with various disorders and improves physical function
Plamumab 40mg Injection (0.8ml Each) is given by a healthcare professional and should not be self-administered
You should use it regularly and at the same time each day to get the maximum benefit from it
Continue using it as recommended by your doctor and complete the dose even if you feel better.
Some of the common side effects of this medicine include headache, sinus inflammation, rash upper respiratory tract infection, and injection site reactions such as pain, redness, and swelling
Talk to your doctor if any of these side effects do not go away with time or get worse
Your doctor may help with ways to reduce or prevent these symptoms.
To make sure the medicine is safe for you, before taking it, let your doctor know if you have any problems with your heart, kidneys, or liver
You should also tell your doctor about all the other medicines you are taking
It is important for pregnant and breastfeeding women to ask the advice of their doctors before taking this medicine.

Cautions

Liver:	CONSULT YOUR DOCTOR: There is limited information available on the use of Plamumab 40mg Injection (0.8ml Each) in patients with liver disease. Please consult your doctor.
Kidney:	CONSULT YOUR DOCTOR: There is limited information available on the use of Plamumab 40mg Injection (0.8ml Each) in patients with kidney disease. Please consult your doctor.
Driving:	UNSAFE: Plamumab 40mg Injection (0.8ml Each) may cause side effects which could affect your ability to drive.^Plamumab 40mg Injection (0.8ml Each) may cause room spinning sensation and vision disturbances. This may affect your driving ability.
Breast feeding:	SAFE IF PRESCRIBED: Plamumab 40mg Injection (0.8ml Each) is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnency:	SAFE IF PRESCRIBED: Plamumab 40mg Injection (0.8ml Each) is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Alcohol:	SAFE: Consuming alcohol with Plamumab 40mg Injection (0.8ml Each) does not cause any harmful side effects.
Drug Action:	Biologic DMARDs (Disease Modifying Anti-Rheumatoid Drugs)
Therapeutic class:	ANTI NEOPLASTICS
Habit Forming:	No
Chemical Class:	Monoclonal antibody (mAb)